Flunisolide Solution
Product Images NDC 50742-317

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 12 technical images submitted to the FDA as part of the official labeling for Flunisolide (NDC 50742-317). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Ingenus Pharmaceuticals, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure (Figure0006)

Figure (Figure0006)
Illustration showing a side profile of a human head with an arrow indicating use or direction towards the nasal passage. This likely demonstrates administration via the nasal route, consistent with nasal solution products.*
FDA Label Image

Figure (Figure0008)

Figure (Figure0008)
An instructional diagram depicting the disassembly of a nasal solution bottle and its spray applicator. The image shows a bottle on the left and the spray nozzle separated on the right, with an arrow indicating the nozzle can be attached or removed from the bottle.*
FDA Label Image

Figure (Figure001)

Figure (Figure001)
An instructional diagram illustrating the parts of a nasal spray unit with a preassembled pump. It shows a hand holding the spray bottle and labels the dust cover, spray tip, and finger rests on the nasal spray bottle.*
FDA Label Image

Figure (Figure02)

Figure (Figure02)
A black and white line drawing showing a person holding a tissue to their nose, suggesting nasal application or treatment.*
FDA Label Image

Figure (Figure03)

Figure (Figure03)
An instructional illustration showing a hand holding a nasal spray bottle while another hand pulls upward on the spray actuator, indicating how to remove or prepare the spray for use.*
FDA Label Image

Figure (Figure04)

Figure (Figure04)
An instructional illustration showing how to use a nasal spray device. The drawing depicts a person holding the nasal spray bottle with the nozzle positioned at the nostril, indicating proper administration technique.*
FDA Label Image

Figure (Figure05)

Figure (Figure05)
An instructional illustration showing a person using a nasal spray. It depicts the individual holding the nasal spray bottle, inserting the nozzle into one nostril, and preparing to spray the solution into the nasal passage.*
FDA Label Image

Figure (Figure07)

Figure (Figure07)
An instructional illustration showing how to place or remove the cap on a nasal spray bottle. The image features a bottle with a spray nozzle and an arrow indicating the direction for removing or attaching the cap.*
FDA Label Image

Figure (Figure09)

Figure (Figure09)
An instructional line drawing showing a hand holding a nasal spray device or syringe partly submerged in liquid, indicating how to prepare or rinse the device before use.*
FDA Label Image

Label (Image0002)

Label (Image0002)
Label for Flunisolide Nasal Solution, USP 0.025% (0.25 mg/mL) nasal spray, with 25 mL volume delivering 200 metered sprays. Manufactured for Ingenus Pharmaceuticals, LLC. The label includes dosage form as nasal solution for intranasal use only, active and inactive ingredients, preservative, storage instructions, and prescription-only status.*
FDA Label Image

Carton (Image001)

Carton (Image001)
The packaging label for Flunisolide Nasal Solution, USP 0.025% by Ingenus Pharmaceuticals, LLC, lists it as a 25 mL solution for intranasal use. It includes dosing details of 25 mcg per spray with 200 metered sprays per bottle. The label also provides storage instructions, active and inactive ingredients, preservation details, and cautions such as 'Rx only' and 'Keep out of reach of children.'*
FDA Label Image

Flunisolide (structural Formula) (Structure0001)

Flunisolide (structural Formula) (Structure0001)
Chemical structure of flunisolide, showing its steroid backbone with fluorine, hydroxyl, ketone, and ester functional groups. The structure is typical of corticosteroid molecules used in nasal solutions.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.